Brands: Rocuronium · Rocuronium Bromide
Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi, USA LLC | generic | 10 | SUPPLYING |
| Hospira, Inc. | brand | 8 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 6 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 3 | SUPPLYING |
| Caplin Steriles Limited | unknown | 2 | SUPPLYING |
| BE Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Eugia US LLC | generic | 2 | SUPPLYING |
| Sandoz Inc | generic | 2 | SUPPLYING |
| ProPharma Distribution | relabeler | 2 | SUPPLYING |
| Shandong New Time Pharmaceutical Co., Ltd. | unknown | 2 | SUPPLYING |
| Steriscience Specialties Private Limited | unknown | 1 | SUPPLYING |
| Phlow Corporation | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
cGMP Deviations: Products were stored outside the drug label specifications. — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — Product was distributed to three direct accounts in NM, AZ and UT.
Rocuronium Bromide Injection — reported in shortage by Eugia US LLC. Therapeutic category: Anesthesia.
Rocuronium Bromide Injection — reported in shortage by Sandoz Inc.. Therapeutic category: Anesthesia.
Rocuronium Bromide Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Anesthesia.
Rocuronium Bromide Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia.
